Financial reports
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
17 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
Current reports
8-K
Departure of Directors or Certain Officers
3 May 24
8-K
Departure of Directors or Certain Officers
22 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results
28 Mar 24
8-K
Index to Financial Statements
27 Nov 23
8-K
American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results
14 Nov 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
8-K
Delivering Better Care Together Investor Presentation September 2023
28 Sep 23
8-K
American Oncology Network and Digital Transformation Opportunities Corp. Announce Completion of Business Combination
26 Sep 23
8-K
Departure of Directors or Certain Officers
20 Sep 23
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
29 Apr 24
424B5
Prospectus supplement for primary offering
7 Dec 23
S-8
Registration of securities for employees
27 Nov 23
S-1/A
IPO registration (amended)
17 Nov 23
S-1
IPO registration
13 Oct 23
D
$0.00 in equity / options / securities to be acquired, 153 investors
28 Sep 23
25-NSE
Exchange delisting
20 Sep 23
425
Business combination disclosure
20 Sep 23
424B3
Prospectus supplement
15 Sep 23
425
Business combination disclosure
15 Sep 23
Proxies
DEFA14A
Additional proxy soliciting materials
8 Mar 23
DEFA14A
Additional proxy soliciting materials
27 Feb 23
DEFA14A
Additional proxy soliciting materials
21 Feb 23
DEF 14A
Definitive proxy
9 Feb 23
DEFA14A
Additional proxy soliciting materials
6 Feb 23
PRER14A
Preliminary revised proxy
3 Feb 23
PRE 14A
Preliminary proxy
17 Jan 23
PREM14A
Preliminary proxy related to merger
6 Jan 23
DEFA14A
Additional proxy soliciting materials
6 Jan 23
DEF 14A
Definitive proxy
8 Nov 22
Other
EFFECT
Notice of effectiveness
7 Dec 23
CORRESP
Correspondence with SEC
4 Dec 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
3 Nov 23
SEC STAFF
SEC staff action: Order
31 Jul 23
EFFECT
Notice of effectiveness
19 Jul 23
CORRESP
Correspondence with SEC
14 Jul 23
CORRESP
Correspondence with SEC
12 Jul 23
UPLOAD
Letter from SEC
10 Jul 23
SEC STAFF
SEC staff action: Order
10 Jul 23
Ownership
3
William Valle
29 Apr 24
4
Stephen Divers
22 Mar 24
4
Stephen Divers
20 Mar 24
4/A
Stephen Divers
22 Jan 24
3/A
Stephen Divers
22 Jan 24
4
Stephen Divers
8 Jan 24
4/A
Stephen Divers
8 Jan 24
4
Change in insider ownership
5 Jan 24
SC 13D
HealthQuest Tactical Opportunities Fund, L.P.
9 Nov 23
3
Garheng Kong
9 Nov 23